Tuesday, 10 May 2022

Covaxin Maker Gets $19 Million For Development Of 'Variant Proof' Vaccine

CEPI on Tuesday said it will provide up to USD 19.3 million (about Rs 149 crore) to Bharat Biotech International, the University of Sydney, and Switzerland-based ExcellGene SA for the development of a...

from NDTV News - Special https://ift.tt/HAad5FK
via
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

HAL-GE Talks On Track, F414 Pricing Dispute Unrelated - Exclusive

Talks between Hindustan Aeronautics Ltd (HAL) and GE Aerospace on the F414 fighter jet engine programme continue to progress as planned, wit...